Spots Global Cancer Trial Database for overall survival
Every month we try and update this database with for overall survival cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment | NCT00839111 | Colorectal Neop... | sorafenib FOLFIRI | 18 Years - 75 Years | Fudan University | |
Prognostic Impact of Anatomical Resection Vs. Non-anatomical Resection for HCC | NCT01236989 | Patients Affect... Disease-Free Su... Overall Surviva... | anatomical live... Non-anatomical ... | - | University of Milan | |
Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) | NCT02260505 | Gastrointestina... Resected Gastro... Non-metastatic High Risk of Re... KIT Gene Mutati... | Imatinib mainte... | 18 Years - | Centre Leon Berard | |
Apatinib Plus Anti-PD1 Therapy for Advanced Osteosarcoma | NCT03359018 | Progression-fre... Overall Surviva... Clinical Benefi... Toxicity | Apatinib SHR-1210 | 11 Years - | Peking University People's Hospital | |
Standardization of Laparoscopic Surgery for Right Hemi Colon Cancer (SLRC) | NCT02942238 | Overall Surviva... Postoperative C... Metastasis Stage, Colon Ca... | CME D3 | 18 Years - 75 Years | Ruijin Hospital | |
Real-world Study for Patients With Advanced Hepatobiliary Tumors | NCT03892577 | Objective Respo... Progression-fre... Overall Surviva... Disease Control... Duration of Res... Five-year Survi... Quality of Life | Precision oncol... | 18 Years - | Peking Union Medical College Hospital | |
Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer | NCT01494558 | Non-Small Cell ... | Chemoradiothera... | 18 Years - 75 Years | ChineseAMS | |
Towards A Better Paradigm for Head and Neck Cancer Treatment Applying Artificial Intelligence. HNC-TACTIC. | NCT05117775 | Head and Neck C... | No intervention... | 18 Years - | Savana Research | |
Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study | NCT03978481 | Gastric Cancer | Helicobacter py... | 19 Years - | Seoul National University Bundang Hospital | |
Durvalumab Long-Term Safety and Efficacy Study | NCT04078152 | Solid Tumor | Durvalumab | 18 Years - 130 Years | AstraZeneca | |
Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations | NCT03799094 | Carcinoma, Non-... | Vitamin C Tyrosine kinase... | 18 Years - 75 Years | Clifford Hospital, Guangzhou, China | |
Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS) | NCT03022448 | Advanced Soft-t... Metastatic Soft... | No Intervention | 60 Years - | GWT-TUD GmbH | |
Cabozantinib in Advanced Salivary Gland Cancer Patients | NCT03729297 | Salivary Gland ... | Cabozantinib | 18 Years - | Radboud University Medical Center | |
Determination of Immune Phenotype in Glioblastoma Patients | NCT02751138 | Glioblastoma Mu... | Surgery | 18 Years - | University of Ulm | |
Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma | NCT01466868 | Diffuse Large B... | MK2206 | 18 Years - 90 Years | Centre Leon Berard | |
Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) | NCT05520138 | Prostatic Neopl... | Enzalutamide Abiraterone ace... | 18 Years - | Pfizer | |
Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy | NCT01175772 | Ovarian Carcino... | Cytophosphan, C... | 20 Years - 80 Years | HaEmek Medical Center, Israel | |
The Clinical Research of Neoadjuvant Chemotherapy Combined Surgery for Locally Advanced Cervical Cancer | NCT02471027 | Cervical Cancer | Neoadjuvant che... | 18 Years - | Capital Medical University | |
Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT01471444 | Disorder Relate... Leukemia Transplantation... | Fludarabine Clofarabine Busulfan Thymoglobulin Stem Cell Infus... Tacrolimus Methotrexate | 3 Years - 70 Years | M.D. Anderson Cancer Center | |
A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments | NCT05152472 | Unresectable Ga... Locally Advance... Metastatic Gast... | Atezolizumab 12... Imatinib 400 MG | 18 Years - | Centre Leon Berard | |
Pringle's Maneuver Versus Selective Hepatic Vascular Exclusion in Hepatectomy | NCT00820339 | Hepatocellular ... | Selective Hepat... Pringle's Maneu... | 18 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital | |
Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer | NCT04439812 | Stomach Neoplas... | Observation | - | Hospital Universitario Ramon y Cajal | |
De-escalation Study for Stage IIa/IIb < 3 cm Seminoma | NCT05529251 | Seminoma Stage II | Radiotherapy bo... Carboplatin AUC... 3 cycles of EP | 18 Years - | Centre Leon Berard | |
Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics) | NCT02013297 | Brain Metastasi... Spinal Tumors Lung Tumors Ependymoma | SBRT treatment | 18 Months - 20 Years | Centre Leon Berard | |
Cabozantinib in Advanced Salivary Gland Cancer Patients | NCT03729297 | Salivary Gland ... | Cabozantinib | 18 Years - | Radboud University Medical Center | |
Radiotherapy After Primary Chemotherapy for Breastcancer | NCT01279304 | Breast Cancer | radiation - no ... radiation: see ... radiation: see ... | - | Maastricht Radiation Oncology | |
Microwave Ablation Versus Laparoscopic Hepatectomy for 3-5cm Hepatocellular Carcinoma | NCT05796700 | Overall Surviva... Progression-fre... Cost | Microwave Ablat... | 18 Years - | Chinese PLA General Hospital | |
Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT01471444 | Disorder Relate... Leukemia Transplantation... | Fludarabine Clofarabine Busulfan Thymoglobulin Stem Cell Infus... Tacrolimus Methotrexate | 3 Years - 70 Years | M.D. Anderson Cancer Center | |
Spleen-Preserving No. 10 Lymph Node Dissection in Gastric Cancer | NCT04050787 | Overall Surviva... | D2 Lymphadenect... D2 lymphadenect... | 18 Years - 80 Years | The First Hospital of Jilin University | |
Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens | NCT01428973 | Graft-Versus-Ho... Hematological M... | Mycophenolate m... Sirolimus | 16 Years - 75 Years | University of Liege | |
Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery | NCT04025840 | Pancreatic Canc... Surgery Epidural Block Dexamethasone Overall Surviva... | Epidural block Dexamethasone | 45 Years - 90 Years | Peking University First Hospital | |
A Prospective Control Study of Cidan Capsule Combined With TACE in Hepatocellular Carcinoma | NCT02253511 | Hepatocellular ... | Cidan capsule | 18 Years - 75 Years | Beijing Weida Cancer Hospital of Chinese Traditional Medical Sciences | |
Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study | NCT03978481 | Gastric Cancer | Helicobacter py... | 19 Years - | Seoul National University Bundang Hospital | |
TILA-TACE in Treatment of Hepatocellular Carcinoma | NCT03910140 | Tumor Response ... Overall Surviva... | TILA-TACE treat... | - | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC | NCT00834158 | Hepatocellular ... | TACE PVE | 20 Years - 65 Years | Eastern Hepatobiliary Surgery Hospital | |
Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 Years | NCT01191060 | Myeloma | Lenalidomide, B... Lenalidomide, B... | 18 Years - 65 Years | University Hospital, Toulouse | |
Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy | NCT01175772 | Ovarian Carcino... | Cytophosphan, C... | 20 Years - 80 Years | HaEmek Medical Center, Israel | |
Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients | NCT04698785 | Bone Sarcoma Osteosarcoma | Treatment by re... Treatment by pl... | 12 Years - | Centre Leon Berard | |
Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer | NCT00970138 | Gastric Carcino... | apatinib tablet | 18 Years - 70 Years | Fudan University | |
Irinotecan and Anlotinib for Epithelioid Sarcoma | NCT05656222 | Objective Respo... Overall Surviva... | VIA combination... | 3 Years - | Peking University People's Hospital | |
Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal Cancer | NCT01895257 | Colorectal Canc... | HAI-90Y radioem... systemic chemot... | 18 Years - 99 Years | Universiteit Antwerpen | |
Radiotherapy After Primary Chemotherapy for Breastcancer | NCT01279304 | Breast Cancer | radiation - no ... radiation: see ... radiation: see ... | - | Maastricht Radiation Oncology | |
dataBase for Analysis of Rectal Cancer Oncological Results | NCT04947020 | Rectal Cancer Metformin Overall Surviva... Lymph Node Meta... Disease-free Su... | Metformin | 18 Years - | Jagiellonian University | |
TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma | NCT01869088 | Hepatocellular ... | Recombinant Hum... Transartery Che... | 18 Years - 70 Years | Sun Yat-sen University | |
Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy | NCT05665920 | Malignant Breas... | Ultra-hypofract... Standard Radiat... | 18 Years - | Instituto Brasileiro de Controle do Cancer | |
Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST) | NCT01323400 | GIST | Pazopanib Best supportive... | 18 Years - 90 Years | Centre Leon Berard | |
A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma | NCT01692678 | Advanced or Met... | Trabectedin Dacarbazine | 15 Years - | Xian-Janssen Pharmaceutical Ltd. | |
The Long-term Effect of D4 Lymphadenectomy for Gastric Cancer | NCT02423278 | Gastric Cancer Surgery Effects of Chem... | Radical Gastrec... Radical Gastrec... S-1+Oxaliplatin | 18 Years - 65 Years | First Affiliated Hospital, Sun Yat-Sen University | |
Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas | NCT04055220 | Bone Sarcoma Osteosarcoma Ewing Sarcoma Chondrosarcoma Undifferentiate... Leiomyosarcoma Angiosarcoma | Treatment by Re... Treatment by Pl... | 12 Years - | Centre Leon Berard | |
Laparoscopic vs Abdominal Radical Hysterectomy In Patients With Early Cervical Cancer | NCT01258413 | Cervical Cancer Postoperative P... | Laparoscopic Ra... Abdominal radic... | 18 Years - | Hospital Nossa Senhora da Conceicao | |
Almonertinib Plus Microwave Ablation in Advanced Non-small Cell Lung Cancer | NCT04755738 | Advanced Non Sm... | Almonertinib pl... | 18 Years - 80 Years | Qianfoshan Hospital | |
Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection | NCT03779035 | Cholangiocarcin... Gall Bladder Ca... | Gemcitabine Capecitabine | 18 Years - | Tianjin Medical University Cancer Institute and Hospital | |
Combination of Metformin With Gefitinib to Treat NSCLC | NCT01864681 | NSCLC EGFR Gene Ampli... Advanced Cancer Stage IIIB NSCL... Stage IV NSCLC | Gefitinib and M... Gefitinib and p... | 18 Years - 75 Years | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries | NCT02247713 | Non Small Cell ... | 18 Years - | The Netherlands Cancer Institute | ||
HRD and Resistance to PAPPi in EOC Patients | NCT05310370 | Epithelial Ovar... Homologous Reco... Homologous Reco... Poly(ADP-ribose... Drug Resistance Progression-fre... Overall Surviva... | Testing of homo... | 18 Years - | Peking Union Medical College Hospital | |
A Novel Technique of HALS With CME and CVL for RCC | NCT02625272 | Colon Neoplasms | Group A | 18 Years - 80 Years | West China Hospital | |
Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma | NCT01875653 | Stage IV Melano... Stage III Melan... | Autologous Dend... Autologous PBMC... | 18 Years - | Lisata Therapeutics, Inc. | |
Single Arm Study of Induction Chemoradiotherapy Combined With Surgery in the Treatment of Locally Advanced SNMM | NCT05009446 | Mucosal Melanom... Sinonasal Melan... | endoscopic surg... intensity-modul... Chemotherapy dr... | 18 Years - | Eye & ENT Hospital of Fudan University | |
SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients | NCT03448549 | Colorectal Canc... Adjuvant Chemot... | Oxaliplatin Tegafur,gimerac... Xeloda | 18 Years - | Peking University Cancer Hospital & Institute | |
Combination of Metformin With Gefitinib to Treat NSCLC | NCT01864681 | NSCLC EGFR Gene Ampli... Advanced Cancer Stage IIIB NSCL... Stage IV NSCLC | Gefitinib and M... Gefitinib and p... | 18 Years - 75 Years | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients | NCT01149109 | Glioblastoma | Temozolomide an... Temozolomide | 18 Years - 70 Years | University Hospital, Bonn | |
PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer | NCT05310305 | Immune Checkpoi... Anti-programmed... Radiotherapy Recurrent Cervi... Metastatic Cerv... Persistent Adva... Objective Remis... Progression-fre... Overall Surviva... Severe Adverse ... | Radiotherapy fo... | 18 Years - | Peking Union Medical College Hospital | |
Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma | NCT01833299 | Hepatocellular ... Face Cancer | TACE-Sorafenib ... TACE | 18 Years - 75 Years | Sun Yat-sen University | |
Focal Radiotherapy Plus Low Dose Craniospinal Irradiation Followed by Adjuvant Chemotherapy in WNT Medulloblastoma. | NCT04474964 | Medulloblastoma... | Low dose Cranio... | 3 Years - 16 Years | Tata Memorial Centre | |
Chromosomal Instability in Ovarian Cancer | NCT05310357 | Epithelial Ovar... High-grade Sero... Chromosomal Ins... Somatic Copy Nu... Survival Outcom... Minimal Residua... Progression-fre... Overall Surviva... | Testing for chr... | 18 Years - | Peking Union Medical College Hospital | |
Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery | NCT04025840 | Pancreatic Canc... Surgery Epidural Block Dexamethasone Overall Surviva... | Epidural block Dexamethasone | 45 Years - 90 Years | Peking University First Hospital | |
Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning | NCT03852407 | Acute Myeloid L... Myelodysplastic... Chronic Myeloid... Myeloproliferat... Myeloproliferat... Acute Lymphoid ... Multiple Myelom... Chronic Lymphoi... Non Hodgkin Lym... Hodgkin Lymphom... | Thymoglobulin Melphalan Fludarabine Cyclophosphamid | 18 Years - 75 Years | University of Liege | |
Radical Prostatectomy and External Beam Radiotherapy in mCRPC With 223Radium-dicloride (RaProRad) | NCT04110782 | Prostate Cancer | Radium223 | - | Azienda Policlinico Umberto I | |
Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer | NCT02999854 | Acute Myeloid L... Acute Lymphobla... Myelodysplastic... | ATIR101 Cyclophosphamid... T-cell depleted... T-cell replete ... | 18 Years - 70 Years | Kiadis Pharma | |
Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer | NCT01412957 | Metastatic Colo... | Best Supportive... Panitumumab | 18 Years - | Amgen | |
Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer | NCT00568529 | Gastric Cancer | Capecitabine an... | 18 Years - 70 Years | Fudan University | |
Predictive Factors of Survival With and Without Repetition With 5 and 10 Years Curative Post-oesophagectomy for Cancer of the Oesophagus | NCT03410758 | Esophageal Canc... Esophageal Surg... Overall Surviva... | 18 Years - | University Hospital, Brest | ||
Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients | NCT06378853 | Pancreatic Canc... | no intervention | 18 Years - | Jinling Hospital, China | |
Efficacy and Safety of Rituximab Plus Zanubrutinib and Lenalidomide for Relapsed and Refractory Diffuse Large B Cell Lymphoma, a Multicenter, Open and Prospective Clinical Trial | NCT05392257 | Overall Surviva... | Rituximab + zan... | 18 Years - 80 Years | Qingdao Central Hospital | |
Liver Transplantation and Uveal Malignant Melanoma | NCT01311466 | Uveal Malignant... | Liver transplan... | 18 Years - 65 Years | Oslo University Hospital | |
Comprehensive Study on the Quality of Life in Cervical Cancer Patients | NCT03967457 | Quality of Life Cervical Cancer Urodynamics Rectum Dynamics Sex Dysfunction Pelvic Floor Di... Ovarian Reserve... Survivorship Disease-free Su... Overall Surviva... | questionnaires ... Urodynamic test... Rectum dynamics... ovarian reserve... | 18 Years - | Peking Union Medical College Hospital | |
Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients | NCT06378853 | Pancreatic Canc... | no intervention | 18 Years - | Jinling Hospital, China | |
Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy. | NCT06248528 | Hepatocellular ... | Liver resection Locoregional th... | 18 Years - 75 Years | Tongji Hospital | |
Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes | NCT01196715 | Myelodysplastic... | Darbepoetin alp... Filgrastim Blood Red Cell ... | 18 Years - | Barts & The London NHS Trust | |
Predict 5-Year Survival in Elderly Gastric Cancer | NCT06208046 | Gastric Cancer Machine Learnin... | 65 Years - | Fujian Medical University |